ArticleMolecular cancer therapeutics2013

IGF-1R targeting increases the antitumor effects of DNA-damaging agents in SCLC model: an opportunity to increase the efficacy of standard therapy.

Charles Ferté et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.